Last reviewed · How we verify
NCT05535101
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
NA trial testing Intermittent theta burst transcranial magnetic stimulation (iTBS) in Craving in 60 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | National Taiwan University Hospital Hsin-Chu Branch |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2022 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2023 |
Drugs / interventions tested
- Intermittent theta burst transcranial magnetic stimulation (iTBS)
- Sham stimulation
Conditions studied
- Craving — all drugs for Craving →
- Depression, Anxiety — all drugs for Depression, Anxiety →
- Amphetamine Addiction — all drugs for Amphetamine Addiction →
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Who can join
Adults 20 to 65, any sex, with Craving or Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to apply the intermittent theta burst transcranial magnetic stimulation (iTBS) treatment and evaluate the effect in improving craving, affective symptoms, and cognitive function for those participants in the community with amphetamine use. An electroencephalography and blood biomarkers will also be examined to explore the possible mechanisms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05535101
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Craving
Currently open trials in the same condition.
- NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
- NCT06582888 — Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder · EARLY_PHASE1 · recruiting
- NCT06247306 — Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption · NA · recruiting
- NCT06105853 — Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder · NA · recruiting
- NCT05666726 — State-dependent Interoception, Value-based Decision-making, and Introspection · NA · recruiting
Other National Taiwan University Hospital Hsin-Chu Branch trials
Trials by the same sponsor.
- NCT06426251 — Photobiomodulation Therapy in Patients Receiving Total Knee Arthroplasty · NA · recruiting
- NCT05879575 — Effects and Pathophysiology of Weight Training on Pregnancy-related Pelvic Girdle Pain (PPGP) · NA · unknown
- NCT07012200 — Effect of Immersive Interactive Nursing Guidance on Anxiety, Cognition, and Self-efficacy in CHD Patients Undergoing Car · NA · terminated
- NCT06103045 — The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function of Stroke at Acute Stage. · NA · completed
- NCT05764278 — The Efficacy and Safety of Early Rehabilitation in Large Vessel Occlusion Patients After Intra-arterial Thrombectomy: A · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05535101 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital Hsin-Chu Branch
- Last refreshed: 10 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05535101.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing